Figure 1.
Treatment algorithm for lower-risk MDS—IPSS-R ≤3.5. CSA, cyclosporine; EMA, European Medicines Agency; FDA, Food and Drug Administration; m, mutated; NCCN, National Comprehensive Cancer Network; TPO, thrombopoietin.19
Treatment algorithm for lower-risk MDS—IPSS-R ≤3.5. CSA, cyclosporine; EMA, European Medicines Agency; FDA, Food and Drug Administration; m, mutated; NCCN, National Comprehensive Cancer Network; TPO, thrombopoietin.19